Looking for a Blood Epigenetic Signature to Predict Female Infertility
Recruiting
Observational Study
Female Infertility
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 43
- Sex
- Female
- Study type
- Observational
- Participants needed
- 1,456 (estimated)
- Sponsor
- Università Vita-Salute San Raffaele · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The present research project aims to study the DNAm mechanisms underlying the reduction of fertility due to the progressive depletion of oocyte quality. Specifically, our project aims to build an epigenetic clock for MGCs by using outcomes that are certainly related to female fertility. The validation of such findings will be carried out on peripheral blood in order to guarantee its non-invasivene…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* 18\< age \<43, Infertile woman undergoing ART, recurrent pregnancy loss
Exclusion Criteria:
* age \< 18 or \> 44, previous ovarian surgery, severe male factor infertility
Contacts